The new class of drugs, SGLT-2 Inhibitors, have been shown to have positive results; which one is false? 1. Reduces BP 2. Reduces Uric Acid 3. Reduces Glucagon 4. Reduces Glucose 5. Reduces Oxidative Stress 6. Reduces Hypotension 7. Reduces HF Risk Did you get the right answer? Follow the link to find out!
Read More »Production Assistant, Diabetes In Control
2nd Marriage Can Mean Expanded Family Obligations
It’s never too early to start talking about the holidays with our patients. For some, it’s a holiday almost every night. Man, 76 years of age, visits with his wife for obesity and type 2 diabetes management. Despite diabetes education, including medical nutritional therapy and medication, he was not losing weight nor were his glucose levels improving…especially his bedtime glucose levels.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #47: Biosynthesis, secretion, and action of glucagon Part 1 of 4
Glucagon, discovered in 1923 as a contaminant of early insulin preparations, has long been a neglected hormone. Glucagon was among the very first polypeptide hormones to be isolated, purified, sequenced, and synthesized. Thanks to the pioneering work of Unger, it was the first polypeptide hormone to become measurable by radioimmunoassay, almost one year before insulin. It has served two Nobel Prize winners as a unique tool, which permitted Sutherland and his associates to discover cyclic AMP (cAMP), and Rodbell and his coworkers to discover the role of G-proteins in cell-membrane receptors.
Read More »Making the HbA1c Value More Accurate
New approach reduces significant errors from about one in three to about one in 10.
Read More »Can Our Economic Insecurity Really Increase Our Risk for Diabetes And Heart Disease?
Job insecurity found to prompt 19% increase in diabetes, myocardial infarction or coronary death risk.
Read More »Head to Head Study: Insulin vs. GLP-1 Receptor Agonists
Study focuses on differences in clinical outcomes between initiating glucagon-like peptide-1 receptor agonist (GLP-1 RAs) vs. insulin treatment in patients with type 2 treated with oral glucose-lowering medications (OGLM).
Read More »Medical Professionals Not Providing Weight-Loss Education to Low Income Adults
Study finds clinicians less likely to counsel less educated, and younger and older patients.
Read More »Question 856
This oral drug class focuses on the incretin system and its use leads to increased postprandial GLP-1 and G1P levels: 1. Bile Acid sequestrants 2. DPP-4 inhibitors 3. Dopamine-2 agonists 4. Alpha-glucosidase inhibitors Did you get it right? Follow the link to find out!
Read More »High Cost of Insulin
What do you feel is the primary reason for the high cost of insulin? 1) Greed 2) Research and Development 3) Corporate Salaries 4) Stockholders Needing a Return on Investment 5) Other Follow the link to share your opinion -- and see what others think!
Read More »DietSensor App
Introducing the new DietSensor app for iOS and Google devices. This App will allow you to scan your food and drinks and get accurate counts to better judge how much insulin to use.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.